Tofacitinib in the treatment of patients with rheumatoid arthritis: position statement of experts of the Polish Society for Rheumatology

about

Tofacitinib in the treatment of patients with rheumatoid arthritis: position statement of experts of the Polish Society for Rheumatology

Item

http://www.wikidata.org/entity/Q58779800

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Tofacitinib in the treatment o ...... olish Society for Rheumatology

@en

Tofacitinib in the treatment o ...... olish Society for Rheumatology

@nl

type

Item

label

Tofacitinib in the treatment o ...... olish Society for Rheumatology

@en

Tofacitinib in the treatment o ...... olish Society for Rheumatology

@nl

prefLabel

Tofacitinib in the treatment o ...... olish Society for Rheumatology

@en

Tofacitinib in the treatment o ...... olish Society for Rheumatology

@nl

P1476

Tofacitinib in the treatment o ...... olish Society for Rheumatology

@en

P2093

Anna Kotulska-Kucharz

http://www.w3.org/2001/XMLSchema#string

Eugeniusz J Kucharz

http://www.w3.org/2001/XMLSchema#string

Marcin Stajszczyk

http://www.w3.org/2001/XMLSchema#string

Marek Brzosko

http://www.w3.org/2001/XMLSchema#string

Marzena Olesińska

http://www.w3.org/2001/XMLSchema#string

Piotr Leszczyński

http://www.w3.org/2001/XMLSchema#string

Piotr Wiland

http://www.w3.org/2001/XMLSchema#string

Sławomir Jeka

http://www.w3.org/2001/XMLSchema#string

Włodzimierz Samborski

http://www.w3.org/2001/XMLSchema#string

P2860

Systematic review and meta-analysis of serious infections with tofacitinib and biologic disease-modifying antirheumatic drug treatment in rheumatoid arthritis clinical trials

A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate

Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group

Evaluation of Real-World Experience with Tofacitinib Compared with Adalimumab, Etanercept, and Abatacept in RA Patients with 1 Previous Biologic DMARD: Data from a U.S. Administrative Claims Database.

Long-term safety of tofacitinib for the treatment of rheumatoid arthritis up to 8.5 years: integrated analysis of data from the global clinical trials.

Efficacy and safety at 24 weeks of daily clinical use of tofacitinib in patients with rheumatoid arthritis.

Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial.

Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized, controlled trial.

Tofacitinib (CP-690,550) in patients with rheumatoid arthritis receiving methotrexate: twelve-month data from a twenty-four-month phase III randomized radiographic study.

The effect of tofacitinib on pneumococcal and influenza vaccine responses in rheumatoid arthritis.

P304

203-211

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5114/REUM.2018.77971

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Maria Majdan

Bogdan Batko

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30237624

http://www.w3.org/2001/XMLSchema#string

P921

immunology

Infections

P932

6142023

http://www.w3.org/2001/XMLSchema#string